至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Transcriptome Analyses in BV2 Microglial Cells Following Treatment With Amino-Terminal Fragments of Apolipoprotein E

Front Aging Neurosci. 2020; 
Tanner B Pollock, Giovan N Cholico, Noail F Isho, Ryan J Day, Tarun Suresh, Erica S Stewart, Madyson M McCarthy, Troy T Rohn
Products/Services Used Details Operation
GenParts™ DNA Fragments … Materials and Methods. Materials. Construction and purification of the amino-terminal fragments 1–151 for ApoE4 (nApoE4 1–151 ) or ApoE3 (nApoE3 1–151 ) was contracted out to GenScript (Piscataway, NJ, United States) … Get A Quote

摘要

Despite the fact that harboring the apolipoprotein E4 () allele represents the single greatest risk factor for late-onset Alzheimer's disease (AD), the exact mechanism by which ApoE4 contributes to disease progression remains unknown. Recently, we demonstrated that a 151 amino-terminal fragment of ApoE4 (nApoE4) localizes within the nucleus of microglia in the human AD brain and traffics to the nucleus causing toxicity in BV2 microglia cells. In the present study, we examined in detail what genes may be affected following treatment by nApoE4. Transcriptome analyses in BV2 microglial cells following sublethal treatment with nApoE4 revealed the upregulation of almost 4,000 genes, with 20 of these genes upregulate... More

关键词

Alzheimer’s disease, BV2 cells, M1 phenotype, RNA-seq, apolipoprotein E4, inflammation, microglia cells, toxicity